Page 200 - Read Online

Author Instructions

Please use Surname and Initial of Forename to refer to an author’s contribution. For example: made substantial contributions
to conception and design of the study and performed data analysis and interpretation: Salas H, Castaneda WV; performed
data acquisition, as well as provided administrative, technical, and material support: Castillo N, Young V.
If an article is single-authored, please include “The author contributed solely to the article.” in this section.

2.3.3.3 Availability of Data and Materials
In order to maintain the integrity, transparency and reproducibility of research records, authors should include this section
in their manuscripts, detailing where the data supporting their findings can be found. Data can be deposited into data
repositories or published as supplementary information in the journal. Authors who cannot share their data should state
that the data will not be shared and explain it. If a manuscript does not involve such issue, please state “Not applicable.” in
this section.

2.3.3.4 Financial Support and Sponsorship
All sources of funding for the study reported should be declared. The role of the funding body in the experiment design,
collection, analysis and interpretation of data, and writing of the manuscript should be declared. Any relevant grant numbers
and the link of funder’s website should be provided if any. If the study is not involved with this issue, state “None.” in this
section.

2.3.3.5 Conflicts of Interest
Authors must declare any potential conflicts of interest that may be perceived as inappropriately influencing the
representation or interpretation of reported research results. If there are no conflicts of interest, please state “All authors
declared that there are no conflicts of interest.” in this section. Some authors may be bound by confidentiality agreements.
In such cases, in place of itemized disclosures, we will require authors to state “All authors declare that they are bound by
confidentiality agreements that prevent them from disclosing their conflicts of interest in this work.”. If authors are unsure
whether conflicts of interest exist, please refer to the “Conflicts of Interest” of Energy Materials Editorial Policies for a full
explanation.

2.3.3.6 Copyright
Authors retain copyright of their works through a Creative Commons Attribution 4.0 International License that clearly
states how readers can copy, distribute, and use their attributed research, free of charge. A declaration “© The Author(s)
2022.” will be added to each article. Authors are required to sign License to Publish before formal publication.

2.3.3.7 References
References should be numbered in order of appearance at the end of manuscripts. In the text, reference numbers should be
placed in square brackets and the corresponding references are cited thereafter. If the number of authors is less than or equal
to six, we require to list all authors’ names. If the number of authors is more than six, only the first three authors’ names are
required to be listed in the references, other authors’ names should be omitted and replaced with “et al.”. Abbreviations of
the journals should be provided on the basis of Index Medicus. Information from manuscripts accepted but not published
should be cited in the text as “Unpublished material” with written permission from the source.
References should be described as follows, depending on the types of works:
Types Examples
Journal articles by Weaver DL, Ashikaga T, Krag DN, et al. Effect of occult metastases on survival in node-negative
individual authors breast cancer. N Engl J Med 2011;364:412-21. [DOI: 10.1056/NEJMoa1008108]
Organization as author Diabetes Prevention Program Research Group. Hypertension, insulin, and proinsulin in
participants with impaired glucose tolerance. Hypertension 2002;40:679-86. [DOI: 10.1161/01.
HYP.0000035706.28494.09]
Both personal authors and Vallancien G, Emberton M, Harving N, van Moorselaar RJ; Alf-One Study Group. Sexual dysfunction
organization as author in 1,274 European men suffering from lower urinary tract symptoms. J Urol 2003;169:2257-61. [DOI:
10.1097/01.ju.0000067940.76090.73]
Journal articles not in Zhang X, Xiong H, Ji TY, Zhang YH, Wang Y. Case report of anti-N-methyl-D-aspartate receptor
English encephalitis in child. J Appl Clin Pediatr 2012;27:1903-7. (in Chinese)
Journal articles ahead of Odibo AO. Falling stillbirth and neonatal mortality rates in twin gestation: not a reason for
print complacency. BJOG 2018; Epub ahead of print [DOI: 10.1111/1471-0528.15541]
Books Sherlock S, Dooley J. Diseases of the liver and billiary system. 9th ed. Oxford: Blackwell Sci Pub;
1993. pp. 258-96.
Book chapters Meltzer PS, Kallioniemi A, Trent JM. Chromosome alterations in human solid tumors. In: Vogelstein
B, Kinzler KW, editors. The genetic basis of human cancer. New York: McGraw-Hill; 2002. pp. 93-
113..
Online resource FDA News Release. FDA approval brings first gene therapy to the United States. Available from:
https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm574058.htm. [Last accessed
on 30 Oct 2017]